Anticonvulsant Screening Program: CounterACT Tract
$3,217,212N01FY2013DANIH
Investigators
Abstract
To screen compounds for their potential anticonvulsant and neuroprotectant efficacy against nerve agents.
View original record on NIH RePORTER →To screen compounds for their potential anticonvulsant and neuroprotectant efficacy against nerve agents.
View original record on NIH RePORTER →